Calamos Advisors’s Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 AAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,000
Closed -$13.7K 1015
2023
Q3
$13.7K Hold
20,000
﹤0.01% 851
2023
Q2
$16K Hold
20,000
﹤0.01% 892
2023
Q1
$17.6K Hold
20,000
﹤0.01% 1015
2022
Q4
$9.33K Hold
20,000
﹤0.01% 1110
2022
Q3
$2K Buy
+20,000
New +$3.43K ﹤0.01% 1241

Calamos Advisors's AAC.WS Position: Q4 2023 in Review

Calamos Advisors sold out of Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (AAC.WS) in Q4 2023, closing a stake of 20,000 shares — an estimated $13.7K sold.

Calamos Advisors first reported a position in AAC.WS in Q3 2022 and held it in 5 quarters. The position peaked at $17.6K in Q1 2023. 0 funds tracked by Wall St. Rank hold AAC.WS as of Q4 2023.

  • Calamos Advisors reported no remaining Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
  • Calamos Advisors sold 20,000 Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2023, an estimated $13.7K.
  • Calamos Advisors first reported a position in Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2022 and held it in 5 quarters.
  • Calamos Advisors's Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $17.6K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2023.

Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.